› $150,000,000 verdict in personal injury case
Dawn Harris says she was never made aware that long-term use of the acid reflux drug Reglan (metoclopramide) could cause her young child to suffer a serious, permanent and disabling neurological injury that results in involuntary movements of the face, arms and torso. The Louisiana mother has filed suit against the makers of the drug, claiming the medication caused her child to develop Tardive Dyskinesia.
A Louisiana man is suing the manufacturer of the acid reflux medication Reglan (metoclopramide) alleging the medication caused him to develop a debilitating nervous system disorder known as tardive dyskinesia. Isreal Bennett of Jefferson Parish filed the suit against Qualitest Pharmaceuticals on June 11, 2010, in federal court in New Orleans.
The U.S. Fifth Circuit Court of Appeals has found in favor with a lower court that patients may sue generic drug makers under state law for failing to provide adequate warnings about potential side effects with their drugs. The ruling extends a 2009 U.S. Supreme Court ruling governing makers of name-brand drugs. The issue of whether generic drug companies should be held liable for not adequately warning consumers has divided several district courts, which can increase the odds of a Supreme Court review in the future, according to U.S. Circuit Judge Patrick Higginbotham.
